Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials

Anthony P.Y. Liu, Brian Gudenas, Tong Lin, Brent A. Orr, Paul Klimo, Rahul Kumar, Eric Bouffet, Sridharan Gururangan, John R. Crawford, Stewart J. Kellie, Murali Chintagumpala, Michael J. Fisher, Daniel C. Bowers, Tim Hassall, Daniel J. Indelicato, Arzu Onar-Thomas, David W. Ellison, Frederick A. Boop, Thomas E. Merchant, Giles W. RobinsonPaul A. Northcott, Amar Gajjar

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences